Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever
Completed · Not applicable · NCT05152524
Conditions: Ischemic Stroke, Neovascularization
At a glance
- Research payments reported, 2025
- $157,789
- U.S. investigators named
- 3
- Sites paid
- 10
- Planned or actual enrollment
- 149
About the trial
- Sponsor
- Rapid Medical
- Tested
- Tigertriever 13 (device)
- Dates
- Started 2022-03-25; completion 2026-03-30
- Results posted
- Not yet
The objective of the DISTALS Study is to evaluate the safety and effectiveness of the Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by removing thrombus in patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO), as compared to medical management.
From ClinicalTrials.gov, last updated 2026-08-12. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Rapid Medical Ltd reported $157,789 in research payments for this study in 2025 (37 payments).
Products named: Tigertriever 17 Revascularization Device
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Jeffrey L. Saver, MD Neurology · Los Angeles, CA
- Rishi Gupta, MD Neurosurgery · Marietta, GA
- David J. Fiorella, M.D., PH.D. Neuroradiology · Stony Brook, NY
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- University at Buffalo Neurosurger $48,928
- Icahn School of Medicine at Mount Sinai $46,818
- Spectrum Health, MI $18,541
- New York University Medical Center $18,274
- Wellstar Health $12,480
- Vascular Neurology of Southern California $6,525
- Advocate Christ Hospital & Medical Center, IL $3,129
- Munson Medical Center, MI $1,845
- Vhs Harlingen Hospital Company LLC, TX $650
- Bon Secours Mercy Health $600
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.